FDA
Sun
Jul 2
— 0.00
Sun Pharmaceutical Industries announced the FDA approval of its generic formulation of spironolactone and hydrochlorothiazide, which will broaden access to this essential oral anti…
FDA
ORGANON
May 6
— 0.00
1. **Analyze the Request:**
* **Source Material:**
* Brand: N/A
* Generic: N/A (Implies it's likely a generic or a brand name from the past, but the data…
FDA
Apotex
Mar 25
— 0.00
# FDA Approves Generic Trazodone Hydrochloride ANDA for Apotex Corp
Apotex Corp received FDA approval for its generic trazodone hydrochloride oral formulation (ANDA071258) on Marc…
FDA
HIKMA
Dec 3
— 0.00
Hikma Pharmaceuticals announced FDA approval for its generic atorvastatin calcium tablets, a strategic addition to its U.S. generics portfolio that positions the company to capture…
FDA
Methapharm
Oct 31
— 0.00
# FDA Approves Methapharm Inc.'s PROVOCHOLINE for Respiratory Testing
Methapharm Inc. received FDA approval for PROVOCHOLINE (methacholine chloride), an inhaled diagnostic agent u…
FDA
AMICI
Jul 16
— 0.00
# FDA Approves Metronidazole Generic for Amici Pharma
Amici Pharma Inc. received FDA approval for its generic oral metronidazole formulation (ANDA070772), expanding the competitiv…
FDA
Mylan
May 13
— 0.00
Mylan Pharmaceuticals Inc. obtained regulatory approval for DOXEPIN HYDROCHLORIDE, deviating from the generic terminology to highlight the brand value associated with the specific …
FDA
STRIDES
Apr 7
— 0.00
# FDA Approves Generic Drug Application for Strides Pharma International
Strides Pharma International received FDA approval for ANDA062538 on April 7, 1986, expanding its portfoli…
FDA
Medline
Dec 17
— 0.00
Medline Industries, LP has secured FDA approval for its foundational Chlorhexidine Gluconate product, a topically applied antiseptic with established market presence dating back to…
FDA
Hikma
Dec 16
— 0.00
# FDA Approves Hikma Pharmaceuticals' Intramuscular Diazepam Formulation
Hikma Pharmaceuticals USA Inc. has received FDA approval for an intramuscular formulation of diazepam, exp…
FDA
Hospira,
Sep 13
— 0.00
# FDA Approves Lidocaine Hydrochloride and Epinephrine for Epidural Use
Hospira, Inc. has received FDA approval for lidocaine hydrochloride and epinephrine as an epidural anesthet…
FDA
ABBVIE
Apr 9
— 0.00
AbbVie Endocrine Inc. announced FDA approval for the product designated NDA019010, a key milestone that is projected to bolster the company's endocrine portfolio and enhance its co…
FDA
ANI
Mar 6
— 0.00
ANI PHARMS has secured FDA approval for ANDA088629, a significant regulatory milestone for the company. This clearance positions ANI PHARMS to enter the relevant market, enhancing …
FDA
Hikma
Jan 30
— 0.00
Hikma Pharmaceuticals USA Inc. announced Friday that the FDA has approved an ANDA for the generic version of meperidine hydrochloride, opening the door for potential additional mar…
FDA
Xttrium
Dec 24
— 0.00
# FDA Approves Chlorhexidine Gluconate Antiseptic Skin Cleanser for Xttrium Laboratories
Xttrium Laboratories, Inc. received FDA approval for its chlorhexidine gluconate topical a…
FDA
BARR
Sep 19
— 0.00
Barr Pharmaceuticals announced today that the FDA has approved its abbreviated new drug application (ANDA088640), acquiring rights to a discontinued drug product with potential imm…
FDA
US
Aug 6
— 0.00
US ANTIBIOTICS announced its subsidiary has received FDA approval for antibiotic compound NDA050564, a backlog item dating back to August 1984, which the company asserts clears the…
FDA
SpecGx
Dec 7
— 0.00
SpecGx LLC received FDA approval for its oral Oxycodone and Acetaminophen generic, signifying a strategic entry into the competitive high-volume generic opioid market. This clearan…
FDA
NOVARTIS
Nov 14
— 0.00
This FDA approval from November 1983 represents a foundational milestone in Novartis's historical portfolio, though the current market impact is negligible as the substance is well…
FDA
Hospira,
Jul 25
— 0.00
# FDA Approves Hospira's Phytonadione (Vitamin K1) for Intramuscular Injection
Hospira, Inc. received FDA approval for phytonadione (Vitamin K1) injection, expanding the availabil…